What is Surgical Innovations Group Revenue per Share?
Surgical Innovations Group's revenue per share for the
six
months ended in Dec. 2023 was £0.01.
Surgical Innovations Group's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.01.
During the past 12 months, the average Revenue Per Share Growth Rate of Surgical Innovations Group was 8.30% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 17.60% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 0.60% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was -1.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Surgical Innovations Group's Revenue per Share or its related term are showing as below:
LSE:SUN'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -30.7 Med: 5.7 Max: 91.3
Current: 17.6
During the past 13 years, Surgical Innovations Group's highest 3-Year average Revenue Per Share Growth Rate was 91.30% per year. The lowest was -30.70% per year. And the median was 5.70% per year.
LSE:SUN's 3-Year Revenue Growth Rate is ranked better than 72.86% of 748
companies
in the Medical Devices & Instruments industry
Industry Median: 7
vs LSE:SUN: 17.60
Surgical Innovations Group Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Surgical Innovations Group Revenue per Share Chart
Competitive Comparison of Surgical Innovations Group's Revenue per Share
For the Medical Devices subindustry, Surgical Innovations Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's PS Ratio falls into.
Surgical Innovations Group Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Surgical Innovations Group's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group (LSE:SUN) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Surgical Innovations Group Revenue per Share Related Terms
Thank you for viewing the detailed overview of Surgical Innovations Group's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Surgical Innovations Group (LSE:SUN) Business Description
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:SUN has been successfully added to your 